头癌中三级淋巴结合物的空间动态:对免疫疗法反应的洞察
Habib Sadeghirad1, James Monkman1, Chin Wee Tan1,2,3
1Frazer Institute, Faculty of Medicine, Translational Research Institute, The University of Queensland, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Journal of translational medicine
|July 25, 2024
概括
在复发性/转移性头支状细胞癌 (R/M HNSCC) 中的三级淋巴体结构 (TLS) 对免疫检查点抑制剂 (ICI) 反应至关重要. 它们与瘤的接近表明结果更好,指导未来的R/M HNSCC治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 复发性/转移性头支状细胞癌 (R/M HNSCC) 预后不佳,治疗选择有限.
- 免疫检查点抑制剂 (ICI) 是标准的护理,但由于瘤微环境 (TME) 的复杂性,其疗效具有变化.
- 三级淋巴体结构 (TLS) 正在成为免疫治疗反应的关键决定因素.
研究的目的:
- 调查TLS在R/M HNSCC对ICI反应中的作用.
- 了解TLS与ICI疗效相关的空间和分子特征.
主要方法:
- 使用多omics方法对两个R/M HNSCC患者队列的分析.
- 使用纳米链GeoMx数字空间分析仪进行有针对性的蛋白质基因分析.
- 在空间上解析了TLS和生殖中心 (GC) 的整个转录组概况.
- 使用Akoya Biosciences Phenocycler Fusion进行TLS的单细胞解析蛋白质基因分析.
主要成果:
- ICI反应者显示"热瘤"表型与T淋巴细胞标记 (CD3,CD45,CD8) 和PD-L1上调.
- 抗原呈现细胞 (CD40,CD68,CD11c,CD163) 和HLA-DR在反应者中升高.
- TLS分析显示免疫调节,免疫细胞招募和干扰素反应基因的增加.
- 更近的TLS-瘤距离与更好的ICI反应有显著的相关性 (H=9.28,p=0.026).
结论:
- TLS在调节R/M HNSCC TME和影响ICI疗效方面发挥着重要作用.
- 空间解析的多主题提供了对ICI响应生物标志物的洞察力.
- 描述TME复杂性对于开发治疗策略和患者分层至关重要.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501


